Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.6400 -0.0230 (-3.47%)

Streaming Delayed Price Updated: 2:26 PM EDT, Apr 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	94,490
Open	0.6730
Bid (Size)	0.6401 (500)
Ask (Size)	0.6459 (200)
Prev. Close	0.6630
Today's Range	0.6400 - 0.6730
52wk Range	0.3625 - 1.910
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

April 01, 2026

White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company...

Via Newsfile

Envoy Medical Reports Full Year 2025 Financial Results

March 23, 2026

Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing...

Via Newsfile

Performance

YTD	-8.0%	-8.0%
1 Month	-5.8%	-5.8%
3 Month	-7.8%	-7.8%
6 Month	-31.2%	-31.2%
1 Year	-50.8%	-50.8%

More News

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

March 11, 2026

Via Newsfile

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

February 24, 2026

Via Newsfile

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

February 23, 2026

Via Newsfile

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

February 19, 2026

Via Newsfile

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

February 17, 2026

Via Newsfile

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

February 12, 2026

Via Newsfile

These stocks have an unusual volume in today's session ↗

February 12, 2026

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

February 12, 2026

Via Chartmill

Which stocks are experiencing notable movement on Wednesday? ↗

February 11, 2026

Via Chartmill

Top stock movements in today's session. ↗

February 11, 2026

Via Chartmill

Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering

February 11, 2026

Via Newsfile

Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing

February 06, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th

February 02, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

January 29, 2026

From Virtual Investor Conferences

Via GlobeNewswire

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

December 18, 2025

Via Newsfile

Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio

December 16, 2025

Via Newsfile

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

December 10, 2025

Via Newsfile

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

December 04, 2025

Via Newsfile

Envoy Medical Announces the Grant of Its 40th U.S. Patent

December 02, 2025

Via Newsfile

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

November 20, 2025

Via Newsfile

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

November 18, 2025

Via Newsfile

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

November 10, 2025

Via Newsfile

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

November 04, 2025

Via Newsfile

Frequently Asked Questions

Is Envoy Medical, Inc. - Class A Common Stock publicly traded?

Yes, Envoy Medical, Inc. - Class A Common Stock is publicly traded.

What exchange does Envoy Medical, Inc. - Class A Common Stock trade on?

Envoy Medical, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Envoy Medical, Inc. - Class A Common Stock?

The ticker symbol for Envoy Medical, Inc. - Class A Common Stock is COCH on the Nasdaq Stock Market

What is the current price of Envoy Medical, Inc. - Class A Common Stock?

The current price of Envoy Medical, Inc. - Class A Common Stock is 0.6400

When was Envoy Medical, Inc. - Class A Common Stock last traded?

The last trade of Envoy Medical, Inc. - Class A Common Stock was at 04/09/26 02:26 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.